Challenging the artificial divide between hematology and vascular medicine.
One System or Two?
We speak comfortably of blood disorders and vascular disease as if they are naturally distinct domains.
Hematology studies the cells and proteins that circulate.
Vascular medicine studies the conduits through which they move.
One discipline focuses on what flows.
The other focuses on where it flows.
The division feels orderly. It is also incomplete.
The Biology We Quietly Share
Circulation is not a bag of cells moving through inert pipes. It is an ongoing negotiation between circulating tissue and living surface.
Platelets do not activate in isolation. They activate on endothelium.
Coagulation factors do not assemble in empty plasma. They assemble on membranes.
Complement does not merely circulate. It deposits.
Leukocytes do not inflame abstractly. They adhere and transmigrate.
Red cells do not simply carry oxygen. They deform, sense shear, and influence viscosity.
The endothelium is not lining. It is a distributed organ, metabolically active, immunologically alert, exquisitely responsive to flow.
Blood is not cargo. It is reactive tissue in suspension.
The functional unit is neither blood nor vessel alone. It is the interface.
If It Walks Like a System
What defines an organ system?
A structure.
A coordinated function.
Integrated regulation.
Shared pathology.
By those criteria, the blood–vessel complex qualifies.
Structure: a continuous endothelial surface interacting constantly with circulating cellular and protein elements.
Function: oxygen delivery, nutrient exchange, hemostasis, inflammation, immunity, thermoregulation, repair.
Integrated regulation: shear alters endothelial gene expression; endothelial signals modulate platelet reactivity; coagulation proteases signal beyond clotting; inflammation reshapes vascular tone and permeability.
Shared pathology: thrombosis, microangiopathy, vasculitis, ischemia–reperfusion injury, sepsis, atherosclerosis, complement-mediated disease.
These are not purely blood problems or purely vascular problems. They are failures of coordination at the interface.
By systems logic, this looks like a unified physiological domain.
A Scene from the Consult Service
The abstraction becomes visible at the bedside.
On hematology consult service, the boundaries reveal themselves in real time.
If a patient has a deep vein thrombosis, we are consulted and we take charge.
If the clot extends into the iliac veins and catheter-directed therapy is considered, we defer to vascular colleagues.
If a patient has an arterial thrombus, we often decline the consult. “That’s vascular.”
Yet if that same arterial clot raises suspicion for an underlying thrombophilia, hematology re-enters the picture.
At times both vascular medicine and hematology are consulted on the same patient. Two teams evaluate the same clot through different conceptual lenses. Recommendations overlap. Language diverges. Time is duplicated.
What is striking is not disagreement.
What is striking is that ownership changes according to anatomy, procedural capability, and training pathway, not according to molecular biology.
The platelet does not recognize whether it is in an artery or a vein.
Thrombin does not consult hospital bylaws.
The endothelium does not differentiate between departmental structures.
Yet we do.
Arterial and Venous: A Useful but Incomplete Distinction
Cardiology and vascular medicine traditionally “own” arterial disease: myocardial infarction, stroke, peripheral arterial disease.
Hematology often “owns” venous disease: deep vein thrombosis, pulmonary embolism, thrombophilia.
The language differs. The biology overlaps.
Arterial thrombosis is described in terms of plaque rupture and shear.
Venous thrombosis is described in terms of stasis and hypercoagulability.
Both require endothelial activation or dysfunction.
Both require platelet participation.
Both require coagulation cascade engagement.
Both unfold within altered flow.
Both are shaped by inflammation.
Virchow’s triad never confined itself to a single specialty.
The arterial–venous distinction is clinically useful. It is not evidence of separate systems. It is variation within one system.
The Cost of Siloed Thinking
When we divide blood from vessel, several distortions follow.
We treat clotting disorders without examining vascular phenotype.
We treat vascular disease without examining hematologic drivers.
We underrecognize microvascular pathology because it belongs to neither camp.
We fragment teaching across rooms and rotations.
Trainees learn coagulation in one context, atherosclerosis in another, vasculitis somewhere else, microangiopathy under yet another lens.
The underlying biology is continuous. The education is not.
The consult vignette is not an anecdote about turf. It is a diagnostic clue about our intellectual architecture.
Not a Merger, but a Reframing
This is not an argument to merge specialties or erase expertise.
It is an argument to recognize a shared system.
We do not separate lung from air.
We do not separate kidney from filtrate.
We do not separate immune system from signaling networks.
Why do we separate circulating tissue from the surface it continuously engages?
Perhaps we should speak explicitly of a hemovascular system, a circulatory interface, a distributed organ composed of blood and vessel acting together.
Language shapes thinking. Thinking shapes structure.
Why This Matters Now
Modern disease increasingly lives at the interface.
Complement-mediated microangiopathy.
Inflammatory thrombosis.
Endotheliopathy in sepsis.
Clonal hematopoiesis and vascular risk.
Immune therapies with vascular toxicity.
Thromboinflammation as a unifying framework.
These conditions do not respect arterial–venous divisions. They do not align neatly with departmental boundaries.
They are failures of regulation between circulating elements and vascular surface.
If there is a natural conceptual expansion for hematology, it may not be adding vascular medicine as an external domain. It may be acknowledging that vascular biology has always been implicit within it.
A Clinical Return
At the bedside of a patient with thrombosis, ischemia, or vascular inflammation, the most important question is not:
Is this hematology or vascular medicine?
It is:
What is happening at the interface between circulating tissue and vascular wall?
Is the blood overly reactive?
Is the endothelium dysfunctional?
Is flow distorted?
Is inflammation amplifying both?
The most complete answers almost always involve all three.
Conclusion
Perhaps blood and the vascular wall are not two separate systems awkwardly cooperating.
Perhaps they are one distributed organ system whose pathology we have artificially subdivided for historical and logistical convenience.
Recognizing this does not require collapsing specialties.
It requires shared language, intellectual humility, and a willingness to look at the interface rather than the silo.
The biology has always been integrated.
Only our organization has been divided.